Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients

Immunotherapy response in immunosuppressed patients with Merkel cell carcinoma: analysis of 183 patients

Objective Merkel cell carcinoma (MCC) is an aggressive skin cancer with poor outcomes in immunosuppressed patients. While immune checkpoint inhibitors (ICIs) achieve ~60% response rates in immunocompetent MCC patients, their efficacy in immunosuppressed patients remains unclear due to exclusion from...

Full description

Saved in:
Bibliographic Details
Main Authors: Paul Nghiem, Daniel S Hippe, Xinyi Fan, Tomoko Akaike, Kristina Lachance, Lisa Tachiki, Song Y Park, Ankita A Menon, Emily Gong, Lauren Zawacki, Allison J Remington
Format: Article
Language:English
Published: BMJ Publishing Group 2025-03-01
Series:BMJ Oncology
Online Access:https://bmjoncology.bmj.com/content/4/1/e000654.full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items